SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-030138
Filing Date
2019-06-06
Accepted
2019-06-06 18:25:25
Documents
1
Period of Report
2019-06-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv523225_4.html 4  
1 OWNERSHIP DOCUMENT tv523225_4.xml 4 11927
  Complete submission text file 0001144204-19-030138.txt   14304
Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address 1 DEXCEL STREET OR AKIVA L3 30600000 972-4-636404
Dexxon Holdings Ltd. (Reporting) CIK: 0001636684 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19883731

Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address
Oren Dan (Reporting) CIK: 0001636701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19883730

Mailing Address 1 DEXCEL STREET OR AKIVA L3 3060000
Business Address 1 DEXCEL STREET OR AKIVA L3 3060000 97246364040
Dexcel Pharma Technologies Ltd. (Reporting) CIK: 0001720007 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19883732

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations